AAAAAA

   
Results: 1-18 |
Results: 18
Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development
Authors: Kaste, SC Jones-Wallace, D Rose, SR Boyett, JM Lustig, RH Rivera, GK Pui, CH Hudson, MM
Citation: Sc. Kaste et al., Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development, LEUKEMIA, 15(5), 2001, pp. 728-734
Late effects in survivors of infant leukemia
Authors: Leung, W Hudson, M Zhu, Y Rivera, GK Ribeiro, RC Sandlund, JT Bowman, LC Evans, WE Kun, L Pui, CH
Citation: W. Leung et al., Late effects in survivors of infant leukemia, LEUKEMIA, 14(7), 2000, pp. 1185-1190
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
Authors: Pui, CH Boyett, JM Rivera, GK Hancock, ML Sandlund, JT Ribeiro, RC Rubnitz, JE Behm, FG Raimondi, SC Gajjar, A Razzouk, B Campana, D Kun, LE Relling, MV Evans, WE
Citation: Ch. Pui et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital, LEUKEMIA, 14(12), 2000, pp. 2286-2294
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia
Authors: Woo, MH Hak, LJ Storm, MC Sandlund, JT Ribeiro, RC Rivera, GK Rubnitz, JE Harrison, PL Wang, B Evans, WE Pui, CH Relling, MV
Citation: Mh. Woo et al., Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia, J CL ONCOL, 18(7), 2000, pp. 1525-1532
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
Authors: Relling, MV Pui, CH Sandlund, JT Rivera, GK Hancock, ML Boyett, JM Schuetz, EG Evans, WE
Citation: Mv. Relling et al., Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia, LANCET, 356(9226), 2000, pp. 285-290
Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia
Authors: Howard, SC Gajjar, A Ribeiro, RC Rivera, GK Rubnitz, JE Sandlund, JT Harrison, PL de Armendi, A Dahl, GV Pui, CH
Citation: Sc. Howard et al., Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia, J AM MED A, 284(17), 2000, pp. 2222-2224
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission - A pediatric oncology group study
Authors: Buchanan, GR Rivera, GK Pollock, BH Boyett, JM Chauvenet, AR Wagner, H Maybee, DA Crist, WM Pinkel, D
Citation: Gr. Buchanan et al., Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission - A pediatric oncology group study, CANCER, 88(5), 2000, pp. 1166-1174
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2591-2596
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2691-2696
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia
Authors: Gajjar, A Harrison, PL Sandlund, JT Rivera, GK Ribeiro, RC Rubnitz, JE Razzouk, B Relling, MV Evans, WE Boyett, JM Pui, CH
Citation: A. Gajjar et al., Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia, BLOOD, 96(10), 2000, pp. 3381-3384
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus
Authors: Relling, MV Hancock, ML Rivera, GK Sandlund, JT Ribeiro, RC Krynetski, EY Pui, CH Evans, WE
Citation: Mv. Relling et al., Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus, J NAT CANC, 91(23), 1999, pp. 2001-2008
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias
Authors: Woo, MH Relling, MV Sonnichsen, DS Rivera, GK Pratt, CB Pui, CH Evans, WE Alberto, AS
Citation: Mh. Woo et al., Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias, CLIN CANC R, 5(3), 1999, pp. 543-549
Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia
Authors: Arnaout, MK Tamburro, RF Bodner, SM Sandlund, JT Rivera, GK Pui, CH Ribeiro, PC
Citation: Mk. Arnaout et al., Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia, J PED H ONC, 21(5), 1999, pp. 431-435
Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup
Authors: Rubnitz, JE Behm, FG Wichlan, D Ryan, C Sandlund, JT Ribeiro, RC Rivera, GK Hancock, ML Relling, MV Evans, WE Pui, CH Downing, JR
Citation: Je. Rubnitz et al., Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup, LEUKEMIA, 13(1), 1999, pp. 19-21
Sex differences in prognosis for children with acute lymphoblastic leukemia
Authors: Pui, CH Boyett, JM Relling, MV Harrison, PL Rivera, GK Behm, FG Sandlund, JT Ribeiro, RC Rubnitz, JE Gajjar, A Evans, WE
Citation: Ch. Pui et al., Sex differences in prognosis for children with acute lymphoblastic leukemia, J CL ONCOL, 17(3), 1999, pp. 818-824
High incidence of secondary brain tumours after radiotherapy and antimetabolites
Authors: Relling, MV Rubnitz, JE Rivera, GK Boyett, JM Hancock, ML Felix, CA Kun, LE Walter, AW Evans, WE Pui, CH
Citation: Mv. Relling et al., High incidence of secondary brain tumours after radiotherapy and antimetabolites, LANCET, 354(9172), 1999, pp. 34-39
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital
Authors: Walter, AW Hancock, ML Pui, CH Hudson, MM Ochs, JS Rivera, GK Pratt, CB Boyett, JM Kun, LE
Citation: Aw. Walter et al., Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital, J CL ONCOL, 16(12), 1998, pp. 3761-3767
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia
Authors: Pui, CH Rubnitz, JE Hancock, ML Downing, JR Raimondi, SC Rivera, GK Sandlund, JT Ribeiro, RC Head, DR Relling, MV Evans, WE Behm, FG
Citation: Ch. Pui et al., Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia, J CL ONCOL, 16(12), 1998, pp. 3768-3773
Risultati: 1-18 |